NCT05909995 Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors Status TERMINATED Phase PHASE1
NCT05907122 A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma Status COMPLETED Phase PHASE3
NCT05902520 Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05900102 Head and Neck Melanoma; Access to Staging and Surgical Treatment Status COMPLETED Phase N/A
NCT05878964 Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors. Status RECRUITING Phase N/A
NCT05877430 Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT05874817 Retrospective Assessment of AE-Related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma Status COMPLETED Phase N/A
NCT05867303 A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05867004 Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma Status RECRUITING Phase N/A
NCT05864144 A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05863052 Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05859074 A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer Status RECRUITING Phase PHASE1
NCT05858736 Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05837767 A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue Status RECRUITING Phase NA
NCT05830058 Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma Status RECRUITING Phase PHASE2
NCT05823246 Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma Status UNKNOWN Phase PHASE2